Release Date: 12/01/11 20:28 Summary: Becoming a substantial holder Price Sensitive: No Download Document 435.76KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling